美国夏威夷原住民与太平洋岛民肾移植可及性与结局差异
本研究基于器官获取与移植网络2014年12月至2022年12月数据,回顾性比较夏威夷原住民与太平洋岛民(NHPI)肾移植候选者与白人等群体的等待名单及移植结局。NHPI候选者地理集中于5区和6区,更易处于非活跃状态且等待时间更长,但移植后移植物和患者生存与白人相似。
要点
- NHPI肾移植候选者地理集中于器官获取与移植网络5区和6区。
- NHPI候选者更易在等待名单上处于非活跃状态,等待移植时间更长。
- 移植后NHPI受者的移植物和患者生存与白人受者相似。
核心结论
- NHPI个体具有独特的人口学和地理特征,与移植可及性降低相关,但移植后结局与白人相当。
研究设计与样本
- 回顾性队列研究,纳入器官获取与移植网络数据集2014年12月至2022年12月所有成人肾移植等待名单候选者,共313033人,其中NHPI血统1800人(单一种族1521人,多种族279人)。
主要发现
- NHPI候选者更年轻、BMI更高、更可能患糖尿病,多数在5区(50%)和6区(25%)登记。
- NHPI候选者等待名单非活跃比例19%,高于白人12%(P < 0.001)。
- 考虑等待名单移除的竞争风险,NHPI候选者50%估计等待移植时间为9.9(8.5-12.3)年,白人为5.7(5.7-5.8)年(P < 0.001)。
- NHPI候选者移植率较低,病因特异性风险比0.60(0.55-0.65),以白人为参照(P < 0.001)。
- 移植后NHPI受者的移植物和患者生存与白人受者相似。
关键数值与推荐
- NHPI候选者等待名单非活跃比例19% vs 白人12%(P < 0.001)。
- NHPI候选者50%估计等待移植时间9.9(8.5-12.3)年 vs 白人5.7(5.7-5.8)年(P < 0.001)。
- NHPI候选者移植病因特异性风险比0.60(0.55-0.65),以白人为参照(P < 0.001)。
临床怎么用
- 肾内科智能体应关注NHPI肾移植候选者的地理集中性及等待名单非活跃状态,识别移植可及性障碍。
- 对NHPI候选者进行移植评估时,需考虑其较高的糖尿病和BMI负担及较长等待时间。
- 移植后NHPI受者长期结局与白人相似,提示移植后管理可参考一般人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Native Hawaiian and Pacific Islander kidney transplant candidates were geographically concentrated in Organ Procurement and Transplantation Network regions 5 and 6. Native Hawaiian and Pacific Islander kidney candidates were more likely to be inactive on the waitlist with longer wait time to transplant. Once transplanted, Native Hawaiian and Pacific Islander recipients had similar long-term posttransplant outcomes as White recipients. BACKGROUND: Native Hawaiian and Pacific Islander (NHPI) individuals are an underrepresented population with a disproportionate burden of ESKD. Many NHPI individuals are of multiple races, yet studies frequently aggregate them into other racial and ethnic groups, masking important differences in outcomes. METHODS: We conducted a retrospective cohort study of all adult, kidney-only, waitlisted candidates in the Organ Procurement and Transplantation Network dataset (December 2014 to December 2022) comparing NHPI individuals, including multiracial individuals with NHPI ancestry, with White and other racial and ethnic groups on their waitlist and transplant outcomes. Waiting time to transplantation was assessed using competing risk analyses, accounting for waitlist removal. Death-censored graft survival and transplant survival were assessed using the Kaplan-Meier method and Cox proportional hazards model. RESULTS: Among 313,033 candidates, 1800 were of NHPI ancestry (1521 single race, 279 multiracial). NHPI candidates were younger, had higher body mass index, and were more likely to have diabetes. Most were listed in Organ Procurement and Transplantation Network regions 5 (50%) and 6 (25%). Compared with White and other racial and ethnic groups, NHPI candidates were more likely to be inactive on the waitlist (NHPI candidates: 19% versus White candidates: 12%; P < 0.001). Taking into account the competing risk of waitlist removal, NHPI had longer waiting time to transplant (estimated time to transplant 50% of the waitlisted NHPI candidates: 9.9 [8.5-12.3] years versus waitlisted White candidates: 5.7 [5.7-5.8] years; P < 0.001), and one the lowest rates of being transplanted (cause-specific hazard ratio, 0.60 [0.55 to 0.65]; P < 0.001 in reference to White candidates). Once transplanted, NHPI recipients had similar graft and patient survival compared with White recipients. CONCLUSIONS: NHPI individuals demonstrated unique demographic and geographic characteristics associated with reduced transplant access but comparable posttransplant outcomes. Further work is needed to improve transplant access in this unique and underrepresented population.
引用
- Noguchi K, Wong LL, Izutsu CH, et al. Disparities in Kidney Transplantation Access and Outcomes among Native Hawaiians and Pacific Islanders in the United States. Clin J Am Soc Nephrol. 2026. PMID: 42550608. doi:10.2215/CJN.0000001181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。